Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-253029
Filing Date
2024-11-07
Accepted
2024-11-07 14:55:56
Documents
2
Group Members
SUNSTONE LIFE SCIENCE VENTURES FUND III K/SSUNSTONE LSV GENERAL PARTNER III APS

Document Format Files

Seq Description Document Type Size
1 SC 13G d836936dsc13g.htm SC 13G 67084
2 EX-99.1 d836936dex991.htm EX-99.1 8518
  Complete submission text file 0001193125-24-253029.txt   77362
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Subject) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91812 | Film No.: 241434831
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address STORE STRANDSTRAEDE 18A COPENHAGEN G7 DK-1255
Business Address STORE STRANDSTRAEDE 18A COPENHAGEN G7 DK-1255 45 20 25 51 42
Sunstone Life Science Ventures A/S (Filed by) CIK: 0001845305 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G